Where Great Ideas gain velocity

Swift Street Capital is a physician-led venture capital firm focused on investing in seed and Series A stage life sciences companies developing innovative human health products and services. The fund is leveraging a broad and collaborative network of premier research universities and entrepreneurs to source deal flow combined with the general partners’ deep domain experience, extraordinary vision, and execution discipline to choose fund investments, help build portfolio companies and guide them to high value exits for investors.

 

Physician-Scientist, Inventor, Entrepreneur, Innovator, and Investor

  • Professor of Surgery, Duke University with 20+ years of clinical practice and scientific research in vascular surgery and biology, including Chief of Vascular Surgery

  • President and CEO, MedBlue Incubator

  • Founder, Chief Medical Officer, and CEO, Humacyte, Inc. (NASDAQ: HUMA); public listing in 2021 through a merger with Alpha Healthcare Acquisition Corp. (SPAC)

  • Founder and CEO, Innavasc, Inc. (sold to Gore Medical; 10X investor return)

  • Raised $200M+ capital and trans and $100M in peer-reviewed grants

  • MD and PhD (Cellular and Molecular Biology) – University of Vermont

 

Entrepreneurial Physician, Seasoned Health Care Executive, and Investor

  • 20+ years of clinical practice as a pediatric cardiologist, including Chair of Pediatrics

  • COO, MedBlue Incubator

  • Adjunct Professor Duke University Fuqua School of Business

  • Chief Medical / Clinical Officer - ALVA10, Sapere Bio, Echo Health Ventures, Mosaic Health

  • Ariel Southeast Angel Partners – Investor and member of life sciences diligence team

  • 24th Infantry Division, US Army 

  • MD, MBA, and BA (Economics) – Duke University